QUOIN PHARMACEUTICALS LT-ADR (QNRX) Stock Balance Sheet
NASDAQ:QNRX - Nasdaq - US74907L4095 - ADR - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.82M | 3.62M | 2.40M | 2.86M | 7.48M | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | N/A | |||
| Marketable Securities | 7.73M | 10.43M | 8.29M | 9.99M | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 944.10K | 869.10K | 591.00K | 520.00K | 1.02M | |||
| Total Current Assets | 12.50M | 14.93M | 11.29M | 13.37M | 8.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 458.30K | 483.30K | 583.30K | 700.00K | 810.00K | |||
| Other Non-Current Assets | 0.00 | 300.00K | 300.00K | 380.00K | 50.00K | |||
| Total Non-Current Assets | 458.40K | 783.30K | 883.30K | 1.09M | 860.00K | |||
| TOTAL ASSETS | 12.96M | 15.71M | 12.17M | 14.46M | 9.36M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 600.00K | 600.00K | 600.00K | 600.00K | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 600.00K | 600.00K | |||
| Accrued Expenses | 3.61M | 2.68M | 2.46M | 2.32M | 2.68M | |||
| Accounts Payable | 644.10K | 905.70K | 526.50K | 610.00K | 920.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 370.00K | |||
| Total Current Liabilities | 4.86M | 4.18M | 3.58M | 3.53M | 4.58M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.17M | 2.32M | 2.92M | 3.52M | 4.12M | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 2.17M | 2.32M | 2.92M | 3.52M | 4.12M | |||
| TOTAL LIABILITIES | 7.03M | 6.50M | 6.51M | 7.05M | 8.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -58.98M | -55.17M | -46.20M | -37.52M | -28.07M | |||
| Additional Paid In Capital | 64.90M | 64.37M | 51.87M | 47.86M | 31.66M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | N/A | N/A | 0.00 | -2.93M | -2.93M | |||
| Shares Outstanding | 20.65M | 256.53K | 28.29K | 57.88M | 640.57K | |||
| Tangible Book Value per Share | 0.27 | 34.11 | 180.17 | 0.12 | -0.23 | |||
| Total Shareholders' Equity | 5.93M | 9.20M | 5.66M | 7.41M | 660.00K | |||
| TOTAL LIABILITIES AND EQUITY | 12.96M | 15.71M | 12.17M | 14.46M | 9.36M | |||
| Statistics | ||||||||
| Debt/Equity | 0.47 | 0.32 | 0.62 | 0.56 | 6.24 | |||
| Current Ratio | 2.57 | 3.57 | 3.15 | 3.79 | 1.86 | |||
| Return On Assets (ROA) | -80.64% | -57.05% | -71.38% | -65.35% | -229.27% | |||
| Return On Equity (ROE) | -176.30% | -97.37% | -153.37% | -127.53% | -3251.52% | |||
All data in USD , ROIC based on taxRate of 0.21